Insights On Outsourced Drug Development
-
Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine
6/25/2026
Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
-
How To Capture Growth In The Expanding Metabolic Drug Market
12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Non Animal Origin Squalene For High-Risk Applications
7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation
11/13/2025
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
4/4/2025
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver?
9/17/2026
Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.
-
Biocatalysis 101: Faster, Greener API Manufacturing
4/20/2026
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
Maintain Control Of Pharmaceutical Water Systems
4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Evaluating Clone Performance And Cell-Specific Productivity
8/6/2026
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
Drug Development Readiness: Interactive Checklist And RACI
7/27/2026
Early decisions can have long-lasting consequences for development timelines, cost, risk, and overall probability of success. Engaging the appropriate disciplines early helps avoid downstream surprises and rework.